title: Invited commentary.
authors.affiliation: Department of Thoracic Surgery, University of Milan, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy. lorenzo.spaggiari@ieo.it
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Spaggiari
authors.forename: Monica
authors.initials: M
authors.lastname: Casiraghi
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D015999:Multivariate Analysis; D011013:Pneumonectomy / Q000401:mortality; D011379:Prognosis; D047368:Tumor Burden; D014571:Urologic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*